BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26271493)

  • 1. Differences between hypothetical and experience-based value sets for EQ-5D used in Sweden: Implications for decision makers.
    Aronsson M; Husberg M; Kalkan A; Eckard N; Alwin J
    Scand J Public Health; 2015 Dec; 43(8):848-54. PubMed ID: 26271493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does the choice of EQ-5D tariff matter? A comparison of the Swedish EQ-5D-3L index score with UK, US, Germany and Denmark among type 2 diabetes patients.
    Kiadaliri AA; Eliasson B; Gerdtham UG
    Health Qual Life Outcomes; 2015 Sep; 13():145. PubMed ID: 26374709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
    Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
    Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crosswalk algorithms for the conversion of mean EQ-5D indices calculated with different value sets.
    Nemes S; Garellick G; Salomonsson R; Rolfson O
    Scand J Public Health; 2016 Jul; 44(5):455-61. PubMed ID: 27090196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comparison of Iran and UK EQ-5D-3L Value Sets Based on Visual Analogue Scale.
    Kiadaliri AA
    Int J Health Policy Manag; 2017 May; 6(5):267-272. PubMed ID: 28812814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the Swedish EQ-5D experience-based value sets in a total hip replacement population.
    Nemes S; Burström K; Zethraeus N; Eneqvist T; Garellick G; Rolfson O
    Qual Life Res; 2015 Dec; 24(12):2963-70. PubMed ID: 26038221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QALY weights for diabetic retinopathy--a comparison of health state valuations with HUI-3, EQ-5D, EQ-VAS, and TTO.
    Heintz E; Wiréhn AB; Peebo BB; Rosenqvist U; Levin LÅ
    Value Health; 2012 May; 15(3):475-84. PubMed ID: 22583458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Swedish experience-based value sets for EQ-5D health states.
    Burström K; Sun S; Gerdtham UG; Henriksson M; Johannesson M; Levin LÅ; Zethraeus N
    Qual Life Res; 2014 Mar; 23(2):431-42. PubMed ID: 23975375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of United States and United Kingdom EQ-5D health states valuations using a nonparametric Bayesian method.
    Kharroubi SA; O'Hagan A; Brazier JE
    Stat Med; 2010 Jul; 29(15):1622-34. PubMed ID: 20209481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating quality weights for EQ-5D (EuroQol-5 dimensions) health states with the time trade-off method in Taiwan.
    Lee HY; Hung MC; Hu FC; Chang YY; Hsieh CL; Wang JD
    J Formos Med Assoc; 2013 Nov; 112(11):699-706. PubMed ID: 24183199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Italian population-based values of EQ-5D health states.
    Scalone L; Cortesi PA; Ciampichini R; Belisari A; D'Angiolella LS; Cesana G; Mantovani LG
    Value Health; 2013; 16(5):814-22. PubMed ID: 23947975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing quality of life in a clinical study on heart rehabilitation patients: how well do value sets based on given or experienced health states reflect patients' valuations?
    Leidl R; Schweikert B; Hahmann H; Steinacker JM; Reitmeir P
    Health Qual Life Outcomes; 2016 Mar; 14():48. PubMed ID: 27005466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of FACT- and EQ-5D-based utility scores in cancer.
    Pickard AS; Ray S; Ganguli A; Cella D
    Value Health; 2012; 15(2):305-11. PubMed ID: 22433762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of EQ-5D index scores derived from the US and UK population-based scoring functions.
    Nan Luo ; Johnson JA; Shaw JW; Coons SJ
    Med Decis Making; 2007; 27(3):321-6. PubMed ID: 17545501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Experience-Based Value Set for the EQ-5D-5L in Germany.
    Leidl R; Reitmeir P
    Value Health; 2017 Sep; 20(8):1150-1156. PubMed ID: 28964448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the cost-effectiveness of buprenorphine in treatment of chronic pain using competing EQ-5D weights.
    Norrlid H; Dahm P; Tennvall GR
    Scand J Pain; 2015 Jan; 6(1):24-30. PubMed ID: 29911578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of contemporaneous EQ-5D and SF-6D responses using scoring algorithms derived from similar valuation exercises.
    Whitehurst DG; Norman R; Brazier JE; Viney R
    Value Health; 2014 Jul; 17(5):570-7. PubMed ID: 25128050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The responsiveness of EQ-5D utility scores in patients with depression: A comparison with instruments measuring quality of life, psychopathology and social functioning.
    Günther OH; Roick C; Angermeyer MC; König HH
    J Affect Disord; 2008 Jan; 105(1-3):81-91. PubMed ID: 17532051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hispanic valuation of the EQ-5D health states: a social value set for Latin Americans.
    Zarate V; Kind P; Chuang LH
    Value Health; 2008 Dec; 11(7):1170-7. PubMed ID: 18489516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. People in states worse than dead according to the EQ-5D UK value set: would they rather be dead?
    Bernfort L; Gerdle B; Husberg M; Levin LÅ
    Qual Life Res; 2018 Jul; 27(7):1827-1833. PubMed ID: 29616427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.